PATENT CLAIM ANALYSIS

Application Number: 15884621
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-09
Patent Classification: ["424", "718000"]

Abstract:
Methods and devices for treating excess mucus accumulation in mammals by administering gaseous inhaled nitric oxide or nitric oxide releasing compounds as a mucolytic agent or expectorant are provided. Delivery of gaseous nitric oxide can be made nasally or orally and is preferably substantially coincident with inhalation of the mammal or based on a synchronous parameter of the mammal's respiratory cycle. Varying therapeutic profiles may be used for the delivery of gaseous nitric oxide depending on the severity of the excess mucus accumulation. Parameters for the therapeutic profiles may include flow rate of nitric oxide containing gas, duration of administration of nitric oxide containing gas, number of breaths for which nitric oxide containing gas is to be administered, and concentrations of therapeutic NO delivered to the airways.

Claim (Index 43):
The method of  claim 41 , wherein the severity of the inflammatory airway disease is scored from 0 to 5, with 5 indicating a most severe condition.

Metadata:
- Claim Count in Document: 122.0
- Percentile: 86.0
- Lexical Diversity: 1.8
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['11595108', '11107618', '12004514', '15305790', '11713344']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7538158302583677
- 35 USC 102 Novelty (BERT): 0.5633186198234779
- Combined Prediction Score: 0.7347661092148787
- Mean Citation Score: 291.5836960000001
- Max Citation Score: 480.2052
- Similarity Product: 330.4612458416462

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test